NSABP Participating Sites
NSABP Participating Sites
批准号:
7350889
负责人:
JENNY C-N CHANG
金额:
$6.62万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-10 至 2012-01-31
关键词:
AftercareBiological MarkersBiologyBreastBreast Cancer Prevention TrialBreast Cancer Prognostic FactorCaringClinicClinicalClinical ServicesClinical TrialsCollaborationsComplementCounty HospitalsDisadvantagedDiseaseERBB2 geneGene AbnormalityGene Expression ProfileGeneral HospitalsGenomicsGoalsGrantHospitalsInvestigationMammary NeoplasmsMedicineMethodist ChurchMinorityNational Surgical Adjuvant Breast and Bowel ProjectNatureNeoadjuvant TherapyNumbersOutcomePatientsPilot ProjectsPopulationPrediction of Response to TherapyPrincipal InvestigatorPrognostic FactorPrognostic MarkerPublicationsRateRecruitment ActivityReproduction sporesResearchResearch InfrastructureResearch PersonnelScientistSiteSouthwest Oncology GroupTP53 geneTamoxifenTechnologyTimeTissuesTranslational ResearchTrastuzumabTumor BiologyValidationWomanWomen&aposs GroupWorkbasecDNA Arrayschemotherapycollegedensityexperiencehormone therapyimprovedmalignant breast neoplasmmemberoncologyresearch studyresponsetreatment trial
中文摘要
贝勒医学院乳房护理中心是一个基础广泛的多学科组织
由致力于探索乳腺癌生物学的研究人员组成,并通过更好的
了解这种生物学,以提高治愈率和治疗疾病。的长处
该中心将补充、加强和扩大NSABP的目标。在过去的五年里,我们
在贝勒医学院建立了临床存在和基础设施,
招募各种患者进行治疗研究。沿着我们的乳房护理中心,
与卫理公会医院合作成立,我们还成功地建立了一个
本·陶布总医院是一家县医院,
一些患有乳腺癌的弱势群体和少数民族妇女,并成功地从这一群体中招募
人口在过去的二十五年里,中心的研究人员在以下方面积累了相当多的专业知识:
预后和预测治疗反应的分子标志物,最近已经扩展到
他们在高通量基因组技术上的努力。通过一只忙碌的合力,
大量的临床服务和建立的临床试验基础设施,沿着科学家和临床医生深入
在翻译和分子标记研究方面经验丰富,我们将能够做出独特的贡献
实现NSABP为所有乳腺癌妇女提供最佳、个性化治疗的目标。
英文摘要
The Breast Care Center at Baylor College of Medicine is a broad based, multidiscipiinary organization
composed of investigators dedicated to exploring the biology of breast cancer, and through a better
understanding of this biology, to improving cure rates and treatments for the disease. The strengths of the
Center will complement, reinforce, and extend the goals of the NSABP. Over the past five years, we have
established a clinical presence and infrastructure at Baylor College of Medicine which facilitates the
recruitment of a wide variety of patients onto treatment studies. Along with our Breast Care Center,
established in collaboration with The Methodist Hospital, we have also been successful in establishing a
dedicated breast oncology clinic at Ben Taub General Hospital, a county hospital which serves a large
number of disadvantaged and minority women with breast cancer, and are successfully recruiting from this
population. Center investigators have developed a considerable expertise over the past twenty-five years in
molecular markers of prognosis and prediction of response to therapy, and most recently have extended
their efforts into high through-put genomic technologies. Through the combined strength of a busy, high
volume clinical service and established clinical trial infrastructure, along with scientists and clinicians deeply
experienced in translational and molecular marker research, we will be able to make a unique contribution
towards the NSABP's goal of optimum, individualized treatment for all women with breast cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dual targeting of PI3K and NOS pathways in Metaplastic BreastCancer (MBC)
-
批准号:10739097
-
项目类别:
-
资助金额:$64.42万
-
财政年份:2023
-
负责人:JENNY C-N CHANG
-
依托单位:
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)
-
批准号:10642669
-
项目类别:
-
资助金额:$59.26万
-
财政年份:2022
-
负责人:JENNY C-N CHANG
-
依托单位:
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)
-
批准号:10393358
-
项目类别:
-
资助金额:$44.89万
-
财政年份:2022
-
负责人:JENNY C-N CHANG
-
依托单位:
Targeting the Inflammasome As a Treatment Strategy for COVID-19 infected cancer patients
-
批准号:10161460
-
项目类别:
-
资助金额:$16.15万
-
财政年份:2016
-
负责人:JENNY C-N CHANG
-
依托单位:
Center for Immunotherapeutic Transport Oncophysics
-
批准号:9752959
-
项目类别:
-
资助金额:$163.83万
-
财政年份:2016
-
负责人:JENNY C-N CHANG
-
依托单位:
Targeting Notch, PI3K-AKT and Other Novel Pathways in Breast Cancer Stem Cells
-
批准号:8111136
-
项目类别:
-
资助金额:$43.39万
-
财政年份:2008
-
负责人:JENNY C-N CHANG
-
依托单位:
Targeting Notch, PI3K-AKT and other novel pathways in breast cancer stem cells
-
批准号:8255996
-
项目类别:
-
资助金额:$44.63万
-
财政年份:2008
-
负责人:JENNY C-N CHANG
-
依托单位:
Targeting Notch, PI3K-AKT and other novel pathways in breast cancer stem cells
-
批准号:7691767
-
项目类别:
-
资助金额:$47.85万
-
财政年份:2008
-
负责人:JENNY C-N CHANG
-
依托单位:
Treatment Resistance Pathways & Targeting Residula Cancers
-
批准号:7385522
-
项目类别:
-
资助金额:$15.52万
-
财政年份:2007
-
负责人:JENNY C-N CHANG
-
依托单位:
NSABP Participating Sites
-
批准号:7558974
-
项目类别:
-
资助金额:$6.78万
-
财政年份:2006
-
负责人:JENNY C-N CHANG
-
依托单位:
NSABP Participating Sites
-
批准号:7220608
-
项目类别:
-
资助金额:$6.65万
-
财政年份:2006
-
负责人:JENNY C-N CHANG
-
依托单位:
Breast cancer response markers to a dual HER1/2 blocker
-
批准号:7082220
-
项目类别:
-
资助金额:$25.98万
-
财政年份:2005
-
负责人:JENNY C-N CHANG
-
依托单位:
Breast cancer response markers to a dual HER1/2 blocker
-
批准号:7235677
-
项目类别:
-
资助金额:$25.22万
-
财政年份:2005
-
负责人:JENNY C-N CHANG
-
依托单位:
Breast cancer response markers to a dual HER1/2 blocker
-
批准号:7618387
-
项目类别:
-
资助金额:$25.22万
-
财政年份:2005
-
负责人:JENNY C-N CHANG
-
依托单位:
Breast cancer response markers to a dual HER1/2 blocker
-
批准号:6967007
-
项目类别:
-
资助金额:$26.6万
-
财政年份:2005
-
负责人:JENNY C-N CHANG
-
依托单位:
Breast cancer response markers to a dual HER1/2 blocker
-
批准号:7408053
-
项目类别:
-
资助金额:$25.22万
-
财政年份:2005
-
负责人:JENNY C-N CHANG
-
依托单位:
MECHANISM OF ACTION OF HERCEPTIN R IN BREAST CANCER
-
批准号:6189385
-
项目类别:
-
资助金额:$14.93万
-
财政年份:2000
-
负责人:JENNY C-N CHANG
-
依托单位:
MECHANISM OF ACTION OF HERCEPTIN R IN BREAST CANCER
-
批准号:6585831
-
项目类别:
-
资助金额:$15.05万
-
财政年份:2000
-
负责人:JENNY C-N CHANG
-
依托单位:
MECHANISM OF ACTION OF HERCEPTIN R IN BREAST CANCER
-
批准号:6378060
-
项目类别:
-
资助金额:$14.95万
-
财政年份:2000
-
负责人:JENNY C-N CHANG
-
依托单位:
Treatment Resistance Pathways & Targeting Residula Cancers
-
批准号:8182290
-
项目类别:
-
资助金额:$23.94万
-
财政年份:--
-
负责人:JENNY C-N CHANG
-
依托单位:
海外基金